Scientists have uncovered a surprising new way that giant embryonic cells divide—without relying on the classic “purse-string” ring long thought essential for splitting a cell in two. Studying ...

NVIDIA Corporation delivered exceptional Q4 and FY26 results, with revenue up 73% and net income up 94% year-over-year. Click ...

We’re gaining speed as we chase our dreams! That said, the road could be a bit rough as the Moon squares Venus, potentially making small slights feel larger than they are. Fortunately, once ...

I KNOW YOU LIKE PASSING THE CREDIT AROUND, BUT WHAT DOES IT MEAN TO WIN NOT ONE, BUT TWO CONSECUTIVE NL MANAGER OF THE YEAR AWARDS? >> YEAH, I JUST FEEL PRIVILEGED, YOU KNOW, THAT I’M GRATEFUL TO BE ...

Elvis Presley in Concert film editor and executive producer Jonathan Redmond about his electric archival portrait of the King.

Inside Las Vegas’s hiring process and its decision to bring aboard the Seahawks’ OC. Plus, Joe Brady’s vision for the Bills and more.

Right now, many companies are worried about how to get more employees to use AI. After all, the promise of AI reducing the burden of some work—drafting routine documents, summarizing information, and ...

If you’re always blaming… check your spiritual hygiene. Iyanla Vanzant breaks down the real work behind self-awareness and healing. Full interview now streaming on our main channel. #IyanlaVanzant ...

3D illustration of high voltage transformer on white background. Even now, at the beginning of 2026, too many people have a sort of distorted view of how attention mechanisms work in analyzing text.

Zepbound works by mimicking the action of two hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). GIP and GLP-1 activate certain receptors (binding sites) ...

The 2025 regular season saw plenty of beautiful chaos from Week 1 all the way to Week 18. Patrick Mahomes will be missing the postseason for the first time in his career, second-year quarterback Drake ...

The first oral GLP-1 medication for weight loss has been approved for use in the U.S. The Wegovy pill, from drugmaker Novo Nordisk, was cleared by the Food and Drug Administration to reduce excess ...